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Inactivation of Bacteria
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Abstract
Increasing resistance of bacteria to antibiotics is a serious worldwide problem, 
and to combat resistant bacteria, new antibacterial approaches are to be developed. 
One alternative to traditional antibiotic therapy is photodynamic antimicrobial 
chemotherapy (PACT). PACT is based on excitation of photosensitizers (PS) 
capable of transferring the absorbed light energy to dissolved molecular oxygen 
causing generation of reactive oxygen species, which irreversibly damage bacte-
rial cell components. The overall efficiency of PACT has been proven for Gram-
positive and Gram-negative bacteria. The effectiveness of PACT can be increased 
by encapsulation of PS in liposomes providing more concentrated delivery of PS, 
enhanced cytotoxicity, improved pharmacokinetic properties, sustained release, 
and prolonged action of the PS. For continuous and reusable application, PS can be 
immobilized in polymers. Chemiluminescence, sonodynamic treatment, and radio-
frequency irradiation allow to perform excitation of PS in the dark without external 
illumination, opening prospects for combating internal infections. Combination of 
PS with antibiotics can gain a synergistic effect, allowing in some cases to overcome 
the resistance of bacteria to antibiotics.
Keywords: photodynamic therapy (PDT), photodynamic antimicrobial 
chemotherapy (PACT), photosensitizer (PS), chemiluminescent antimicrobial 
chemotherapy (CPAT), sonodynamic antimicrobial chemotherapy (SACT),  
targeted drug delivery, liposomes, immobilization
1. Introduction
1.1 History of photodynamic therapy
The therapeutic properties of light were observed already in ancient Greece, 
Egypt, and India. However, they were not widely used for many centuries [1]. The 
history of modern photodynamic therapy (PDT) dates back to 1900, when Oscar 
Raab discovered the toxic properties of the dye acridine red on Paramecium spp. 
[2]. He and his supervisor, Hermann von Tappeiner, noticed a positive effect of 
illumination on the toxic activity of this dye. In his later work, von Tappeiner and 
his colleagues applied this approach to inactivation of bacteria [3] and to treatment 
of skin cancer [4]. In 1909, von Tappeiner introduced the term “Photodynamic 
Action” and showed that oxygen is essential for this procedure [5]. PDT has been 
studied and developed as an anticancer therapy for a long time and was approved 
by the Food and Drug Administration in the 1990s for various applications in this 
area of medicine [6–8]. The antimicrobial properties of this approach were unfairly 
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forgotten for several decades. However, interest in antibacterial PDT has been 
rekindled and is continuously increasing because multidrug resistance of patho-
genic microorganisms has become a serious threat to public health. Photodynamic 
antibacterial chemotherapy (PACT) has become a promising approach for combat-
ing bacterial infections, which are resistant to modern antibiotics.
1.2 Photosensitizers and their mechanism of action
PACT is based on the exposure of bacteria to photosensitive compounds—pho-
tosensitizers (PSs). When a PS located in the bacteria or on the bacterial surface 
is exposed to light (usually visible), it transfers from its low-energy ground state 
to an excited singlet state. Return of the PS to its ground state is accompanied by 
either emission of fluorescence or transition of the PS to a longer-living, higher-
energy triplet state (PS*) via intersystem crossing. The PS* in turn reacts with 
surrounding molecules to form free radicals and hydrogen peroxide (Type I reac-
tion) or transfers its energy to molecular oxygen to produce singlet oxygen and 
other highly reactive oxygen species (ROS; Type II reaction) [9, 10]. Type I and 
Type II reactions occur simultaneously, and the ratio at which they occur depends 
on both the PS type and the surrounding conditions. A detailed description of the 
photosensitization process can be found in the recent reviews of Castano et al. [11] 
and Cieplik [10]. ROSs formed in this process oxidize biomolecules, damage the cell 
membrane, and ultimately lead to cell death [12]. PACT usually proceeds predomi-
nantly through Type II processes. However, since Gram-negative bacteria are more 
susceptible to OH. radicals than to singlet oxygen, the Type I reaction may be more 
efficient against such microorganisms [13, 14].
1.3 Photosensitizers for PACT
Hundreds of compounds are currently available for mediating PDT in various 
areas of medicine, where some have been shown to be suitable for antimicrobial 
applications. PSs employed for medical uses should be a single pure compound, 
stable at room temperature and inexpensive. The PS must have a strong absorption 
peak in the visible spectrum between 600 and 900 nm and should possess a high-
triplet quantum yield that will provide high production of ROS upon illumination. 
It should not be toxic in the dark (especially to mammalian cells), mutagenic or 
carcinogenic [15–18]. In addition, when talking about PACT, it is very important 
that the PS will display preferential association with bacteria, accumulate within 
the cells, or bind to the bacterial cell envelope [14, 19].
PSs can generally be assigned to several chemical classes: tetrapyrroles (which 
include porphyrins, chlorins, bacteriochlorins, and phthalocyanines), synthetic 
dyes (phenothiazinium salts, Rose Bengal, squaraines, etc.), and naturally occur-
ring compounds (such as riboflavin or curcumin). Cyclic tetrapyrroles present the 
most well-known class of clinically relevant PSs used mostly for anticancer applica-
tions [20]. This structure can be found naturally in such important biomolecules 
such as haem, chlorophyll, and bacteriochlorophyll. Unlike other types of PSs, 
most tetrapyrroles (except for bacteriochlorins) are more likely to react by a Type II 
reaction with the creation of singlet oxygen [16], whereas bacteriochlorins act via a 
Type I mechanism. Other well-known antimicrobial agents are phenothiazinium-
based synthetic dyes, including methylene blue (MB) and toluidine blue O (TBO), 
which also act as anticancer agents in PDT. These structures can be synthesized 
more easily than tetrapyrroles but possess high-dark toxicity compared to other PSs 
[15, 21]. Another representative of synthetic dyes, Rose Bengal (RB), has already 
been used successfully in antimicrobial and anticancer applications for a long 
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time [16]. Photodynamic active compounds isolated from plants arouse particular 
interest. These natural compounds include curcumin, extracted from the rhizomes 
of Curcuma longa, which was found effective in eradicating oral pathogens [22]. 
Another representative of this group is hypericin isolated from St. John’s wort, 
which exhibits photodynamic activity against Gram-positive and Gram-negative 
bacteria. Detailed descriptions of all PS classes can be found in the reviews pub-
lished by Hamblin and colleagues [15, 16].
2. Photosensitizer activation modes
2.1 Dark activity
The name photosensitizer implies the need for illumination in order to activate 
PS molecules and trigger their action. However, PSs possess some so-called “dark 
activity” even in the absence of illumination, leading to cell death in the dark 
[23–29]. This feature depends on the PS concentration and manifests itself in differ-
ent ways for various PSs.
Shrestha demonstrated dark toxicity of RB against Gram-positive Enterococcus 
faecalis. Exposure of the cells to 10 μM RB in the absence of illumination for 15 min 
led to a 0.5 log10 reduction in cell concentration [26]. Furthermore, a marked dark 
toxicity of RB against clinical isolates of Gram-negative Pseudomonas aeruginosa 
was observed by Nakonieczna [27]. Brovko compared the activity of various PSs 
against several types of microorganisms and noted high dark toxicity of RB, as well 
as of phloxine B against Gram-positive Bacillus sp. and Listeria monocytogenes (more 
than 5 log10 reduction in the bacterial concentration after 30 min of treatment 
with the dye) [30]. The toxicity of malachite green in the dark against the same 
microorganisms was very low (<0.1 log10 reduction in concentration after 30 min of 
treatment with the dye). High concentrations (>500 μg/mL) of acriflavin neutral in 
the absence of light were significantly toxic to E. coli (more than 6 log10 reduction in 
concentration after 30 min of treatment with the dye, both under illumination and 
Figure 1. 
Effect of RB concentration on its cytotoxic activity. S. aureus cells at the initial concentration of 104 CFU mL−1 
were incubated for 3 min in dark conditions at various concentrations of RB. After the incubation, bacteria 
were tested by viable count. Error bars present standard deviations.
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as dipalmitoylphosphatidylcholine, dipalmitoylphosphatidylglycerol, dioleoylphos-
phatidylcholine, and others, were found to be effective on HT29 and Meth A tumor 
models in vivo [62]. However, the only clinically approved liposomal PS drug to 
date is Visudyne, developed by QLT in Vancouver, and produced by Novartis AG, 
Switzerland. This formulation is produced from a derivative of benzoporphyrin 
monoacid encapsulated in unilamellar dimyristoylphosphatidylcholine/egg 
phosphatidylglycerol liposomes. The liposomes in this drug not only dissolve the 
Figure 6. 
MIC values of free and liposome encapsulated MB and NR determined against (a) S. aureus and (b) E. coli. 
Liposomes were prepared from dipalmitoyl phosphatidylcholine and dimyristoyl phosphatidylglycerol at 15 mg/
mL total lipid concentration by sonication for 10 sec. Bacteria at 3 × 104 CFU mL−1 concentration were treated 
by MB and NR at doubled dilutions, illuminated at room temperature by white light of 1.6 mW cm−2 intensity 
for 1 h, and incubated overnight in the dark by shaking at 37°C. Error bars present standard deviations.
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lipophilic PS for intravenous administration but also contribute to its enhanced 
absorption in tumor tissues [62, 64].
Liposomal PS preparations are suitable for antibacterial applications. This 
approach ensures the delivery of the compound at a higher concentration, thus 
increasing the cytotoxicity of the drug. In addition, the local use of liposomal 
preparations provides a slow release of active components, which helps prolong 
their effect in infected tissues. In Gram-negative bacteria, fusion between lipo-
somes and the outer cell membranes leads to the delivery of concentrated liposome 
contents directly into the cytoplasm [70–72]. In Gram-positive bacteria, the PS is 
probably released when liposomes interact with the external peptidoglycan and 
diffuse through the cell wall [72–74]. Various researchers have demonstrated the 
effectiveness of liposomal formulations of various PSs against Gram-positive and 
Gram-negative microorganisms and also against fungal infections in vitro and 
in vivo. Ferro et al. showed high efficacy of porphyrin incorporated into cationic 
liposomes against S. aureus, compared to the free drug [75, 76]. Tsai also showed an 
increase in the bactericidal efficacy of hematoporphyrin against a number of Gram-
positive bacteria, including S. aureus, as a result of its incorporation into liposomes 
[77]. Yang proved the efficacy of chlorine e6 encapsulated in cationic liposomes 
against susceptible and drug-resistant clinical isolates of C. albicans both in vitro 
and for infected burn wounds in vivo [78].
In our studies, we tested the effect of different PSs in different liposome 
formulations on Gram-positive and Gram-negative bacteria. Figure 6 presents a 
comparison between the MICs of free and dipalmitoyl phosphatidylcholine and 
dimyristoyl phosphatidylglycerol liposome-encapsulated MB and NR against S. 
aureus (Figure 6a) and E. coli (Figure 6b).
Figure 7. 
Chemiluminescent photodynamic antimicrobial treatment effect on the viability of S. aureus and E. coli. Cells 
were incubated with 25 μM MB liposome (lip) encapsulated together with 0.7 mM luminol (LM). After the 
treatment, the bacteria were tested by viable count. Error bars present standard deviations.
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As can be seen from the results, incorporation into liposomes significantly 
increased the antibacterial activity of MB and NR. Following encapsulation, the 
MIC of MB decreased by approximately 2-fold and that of NR by about 1.4-fold for 
both tested microorganisms (Figure 6). We tested the effect of liposome composi-
tion on the delivery of these PSs to cells and determined the conditions for efficient 
use of encapsulated PSs [74].
In addition, we tried to apply liposomal forms of PSs to CPAT by encapsulating 
not only PSs in liposomes but also luminol and introduced to activate PSs in sites 
inaccessible to external lighting [59]. We monitored the survival of the cells fol-
lowing their exposure to either liposomal MB or luminol, as well as to liposomes 
containing both compounds together (Figure 7) when the experiments were carried 
out in the dark.
It can be seen (Figure 7) that luminol itself did not lead to cell damage. MB in 
the liposomal form exhibited certain dark activity, similar to that in a free form 
discussed in the “Dark Activity” section. The addition of luminol to MB liposomes 
markedly increased its antibacterial activity toward S. aureus and E. coli. Liposomes 
were not targeted in this study. Targeting of liposomes can lead to an additional 
increase in the efficiency and specificity of this technique.
4. Immobilization
New prospects of using PSs are opened by the immobilization of PSs onto a 
solid phase. This approach may allow repeated or continuous use of PSs. PSs can be 
immobilized by adsorption and covalent bonding onto solid supports and by ionic 
bonding to ion-exchange resins or incorporation into polymer films. The photo-
dynamic properties of immobilized PSs are reported to be retained for a long time 
[79–83]. PSs studied in the immobilized form include RB, MB, and TBO; the por-
phyrin derivatives 5,10,15,20-tetrakis (p-hydroxy phenyl) porphyrin, 5,10,15,20-tet-
rakis (p-aminophenyl) porphyrin, and zinc (II) phthalocyanine tetrasulfonic acid; 
and the ruthenium salts tris (4,4′-diphenyl-2,2′-bipyridine) ruthenium (II), tris 
(4,7-diphenyl-1,10-phenanthroline) ruthenium (II), tris (1,10-phenanthrolinyl-
4,7-bis (benzenesulfonate) ruthenate (II), and tris (4,40-dinonyl-1,10-phenan 
throline) ruthenium (II). Solid supports applied for immobilization of PSs include 
polyethylene, polypropylene, polystyrene, polycarbonate, polymethyl methacrylate, 
polyester isophthalic resin, silicone, cationic nylon, porous silicones, poly (vinyli-
dene difluoride), cellulose membranes, and chitosan [82–88]. Immobilized PSs 
demonstrated antibacterial properties against Gram-negative and Gram-positive 
bacteria in batch and continuous regimes and under reuse. Immobilized PSs were 
found more stable and resistant to photobleaching than in a free form [82, 86, 88].
Our group immobilized PSs in polymers using several techniques. The first 
method included mixing solutions of PSs in chloroform with solutions of polymers 
in the same solvent, followed by evaporation of the solvent, which yielded thin 
polymeric films with homogeneously incorporated PSs. This technique was applied 
to RB and MB immobilized onto polystyrene, polycarbonate, and polymethyl 
methacrylate [88–90]. In all cases, the obtained polymer films showed high anti-
bacterial activity against Gram-positive and Gram-negative bacteria when exposed 
to an external source of white light. However, since this method involves using 
an organic solvent, it cannot be considered environmentally friendly. The second 
method is based on dissolution of PSs in a melted polymer under extrusion and 
does not require any additional chemical reagents [91]. The photosensitizers RB, 
Rose Bengal lactone, MB, and hematoporphyrin were immobilized in polyethylene 
and polypropylene using this method. The antibacterial efficiency of immobilized 
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PSs obtained as polymeric strips and beads was tested against S. aureus and E. coli 
in batch and continuous regimes under white fluorescent light. All immobilized PSs 
significantly reduced the concentration of the tested microorganisms, up to their 
complete eradication [91].
Another immobilization technique was based on polymerization of silicon in the 
presence of RB as the photosensitizer. Silicon tablets produced by this method con-
tained evenly distributed RB that was not bound to the support by covalent bonds 
[29]. The antibacterial activity of the immobilized RB was tested under illumination 
and using ultrasonic activation in the dark (Figure 8). Figure 8 demonstrates the 
effect of immobilized RB on S. aureus cells when subjected to ultrasound in the 
dark. Silicone alone did not affect the microorganisms with and without sonication. 
However, the number of alive cells in samples subjected to immobilized RB under 
sonication decreased with sonication time and decreased by more than three orders 
of magnitude after 10 min of treatment.
Further development of immobilization methods and different PSs and 
polymers may expand the possibilities of this approach and yield the applica-
tions in various fields, such as the production of antibacterial surfaces and water 
disinfection.
5. Conclusions
Numerous studies show that photodynamic antibacterial chemotherapy is a 
powerful tool for killing microorganisms. Since this method requires external 
illumination, it can be successfully applied only to the treatment of local superfi-
cial skin and oral cavity infections. Development of new modes of PS excitation 
by ultrasound, radio waves, chemiluminescent, and bioluminescent light opens 
new prospects for their use in treating internal infections. Encapsulation of PSs in 
liposomes may solve the problem of using hydrophobic PSs with poor solubility 
in the aqueous phase. It can also provide delivery of a concentrated PS directly to 
the target site, thus increasing efficiency and reducing side effects of the treat-
ment. Immobilization of PSs in a solid phase enables using them repeatedly or in 
Figure 8. 
Antibacterial activity of silicon-immobilized RB (5% w/w) under ultrasonic treatment in the dark. 
Control—S. aureus cells treated by ultrasound only. After the treatment, bacteria were tested by viable count. 
Error bars present standard deviations.
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